The increasing prevalence of antibiotic-resistant bacteria challenges a clinician's ability to fight life-threatening infections. Administering beta-lactams via extended infusion may improve patient outcomes. This article discusses the underlying principles of this therapeutic approach and when it may be appropriate.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/01.JAA.0000480576.16121.88 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!